The Insulin in Dosage Market Size Value Per Capita in Austria has shown fluctuations over the past decade. From 2012 to 2022, the values have seen both increments and decrements. Specifically, the year 2021 saw the highest value at 12.17, with a slight decline to 11.1 in 2022. Year-on-year, the market experienced a 6.77% increase from 2020 to 2021 and a 9.63% decrease from 2021 to 2022. Over the last five years, the market’s CAGR has been approximately 0.21%, indicating a stable yet modest long-term growth. In 2023, the value stood at 11.25.
Future trends to watch for include advancements in insulin delivery technologies, increasing prevalence of diabetes, and potential regulatory changes. The market is also expected to be influenced by innovations in biosimilar products and a greater emphasis on personalized medicine. Monitoring these factors will be crucial for understanding the future dynamics of the insulin market in Austria.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 15 | 15 Lithuania | 12.65 | 2023 | View data | ||
| 16 | 16 Ireland | 11.52 | 2023 | View data | ||
| 17 | 17 Austria | 10.77 | 2023 | |||
| 18 | 18 Poland | 8.14 | 2023 | View data | ||
| 19 | 19 Switzerland | 6.34 | 2023 | View data | ||
